Product Pipeline (Biotech - Pharma)

Our product pipeline includes several products already commercialized in diferent indications. We are preparing for a pre-IND meeting with the FDA for our leading compound.


A product dedicated to prevent and treat a condition caused by the use of fertility drugs. The company plans to submit the IND later in 2017.

Other Projects

Two other product candidates are being evaluated for development STI2833 and STI2610. The first product to be used in Controlled Ovarian Stimulation (COS) in ART and the second one an innovative delivery system for administering a hormone in patients undergoing OI and ART.


Steptoe Therapeutics Inc. - All rights reserved
10 Keith Way, Suite 3. - Hingham, MA 02043 - USA - Ph.: +1-781-556-5012 - Fax: +1-781-735-5899